| 08/07/2026 4:10 PM | Celularity (1752828) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/22/2026 3:24 PM | Celularity (1752828) Subject Nasdaq Stock Market LLC (1354457) Filed by | Form 25-NSE | |
| 06/30/2026 8:00 AM | Celularity (1752828) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/25/2026 4:27 PM | Celularity (1752828) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/23/2026 9:12 AM | Barach Daniele Wolf (2126385) Reporting Celularity (1752828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/23/2026 9:13 AM | Barach Philip Alan (2106805) Reporting Celularity (1752828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/23/2026 9:14 AM | Celularity (1752828) Issuer Philip & Daniele Barach Family Trust (2107059) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/23/2026 5:02 AM | Celularity (1752828) Subject Philip & Daniele Barach Family Trust (2107059) Filed by | Form SCHEDULE 13D/A | |
| 06/12/2026 4:15 PM | Celularity (1752828) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/03/2026 4:22 PM | Celularity (1752828) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/28/2026 3:54 PM | Celularity (1752828) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for CELUW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Celularity and its competitors with MarketBeat's FREE daily newsletter.
|
| 04/30/2026 3:06 PM | Celularity (1752828) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 04/24/2026 5:40 PM | Celularity (1752828) Issuer Philip & Daniele Barach Family Trust (2107059) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/24/2026 5:41 PM | Barach Daniele Wolf (2126385) Reporting Celularity (1752828) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/24/2026 5:41 PM | Barach Philip Alan (2106805) Reporting Celularity (1752828) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/22/2026 9:16 AM | Celularity (1752828) Subject Philip & Daniele Barach Family Trust (2107059) Filed by | Form SCHEDULE 13D/A | |
| 04/21/2026 8:05 AM | Celularity (1752828) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/15/2026 3:30 PM | Celularity (1752828) Issuer Hariri Robert J (1398815) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 3:30 PM | Celularity (1752828) Issuer Haines John R (1867686) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 3:30 PM | Brigido Stephen (1869791) Reporting Celularity (1752828) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 10:08 AM | Celularity (1752828) Subject Philip & Daniele Barach Family Trust (2107059) Filed by | Form SCHEDULE 13D | |
| 03/31/2026 4:13 PM | Celularity (1752828) Filer | Form NT 10-K | |
| 03/10/2026 8:00 AM | Celularity (1752828) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/21/2026 3:30 PM | Celularity (1752828) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/15/2026 3:15 PM | Celularity (1752828) Issuer Ling Geoffrey M.D. (1800097) Reporting | Form 4/A | |
| 01/15/2026 3:15 PM | Celularity (1752828) Issuer LeVien Vincent (2076464) Reporting | Form 4/A | |
| 01/15/2026 3:15 PM | Celularity (1752828) Issuer Diamandis Peter (1528288) Reporting | Form 4/A | |
| 01/15/2026 3:15 PM | Celularity (1752828) Issuer Parks Diane L. (1781026) Reporting | Form 4/A | |
| 01/14/2026 7:55 PM | Celularity (1752828) Issuer Ling Geoffrey M.D. (1800097) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/14/2026 7:51 PM | Celularity (1752828) Issuer Parks Diane L. (1781026) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/14/2026 7:51 PM | Celularity (1752828) Issuer Diamandis Peter (1528288) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/14/2026 7:53 PM | Celularity (1752828) Issuer LeVien Vincent (2076464) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/07/2026 11:15 PM | Celularity (1752828) Filer | Form EFFECT | |
| 01/08/2026 5:15 AM | Celularity (1752828) Filer | Form 424B3 | |
| 12/31/2025 3:15 PM | Celularity (1752828) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 12/30/2025 3:30 PM | Celularity (1752828) Issuer Diamandis Peter (1528288) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/30/2025 3:30 PM | Celularity (1752828) Issuer Parks Diane L. (1781026) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/30/2025 3:30 PM | Celularity (1752828) Issuer Ling Geoffrey M.D. (1800097) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/30/2025 3:30 PM | Celularity (1752828) Issuer LeVien Vincent (2076464) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/29/2025 11:15 PM | Celularity (1752828) Filer | Form EFFECT | |
| 12/30/2025 5:04 AM | Celularity (1752828) Filer | Form 424B3 | |
A $382 trillion migration and the position no one is talking about (Ad) Trump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money network by April 2027. BlackRock CEO Larry Fink already calls it 'the next major evolution in market infrastructure.'
Our research has identified one small, overlooked position at the center of this policy-driven shift - already drawing quiet institutional buying from BNY Mellon, State Street, and JPMorgan. It currently trades for pennies relative to where institutional demand could push it. The Q3 2026 compliance deadline may be the last window before prices move. Click here to see the full research and the position name |
| 12/23/2025 3:15 PM | Celularity (1752828) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/22/2025 3:30 PM | Celularity (1752828) Issuer Diamandis Peter (1528288) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/22/2025 3:30 PM | Celularity (1752828) Issuer Ling Geoffrey M.D. (1800097) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/22/2025 3:30 PM | Celularity (1752828) Issuer Parks Diane L. (1781026) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/19/2025 3:15 PM | Celularity (1752828) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/19/2025 3:15 PM | Celularity (1752828) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 12/05/2025 3:30 PM | Celularity (1752828) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/21/2025 3:15 PM | Celularity (1752828) Issuer Diamandis Peter (1528288) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/21/2025 3:15 PM | Celularity (1752828) Issuer Ling Geoffrey M.D. (1800097) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/21/2025 3:17 PM | Celularity (1752828) Issuer LeVien Vincent (2076464) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/21/2025 3:17 PM | Celularity (1752828) Issuer Parks Diane L. (1781026) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/07/2025 4:08 PM | Celularity (1752828) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 11/07/2025 12:13 PM | Celularity (1752828) Filer | Form DEF 14A | |
| 11/07/2025 12:19 PM | Celularity (1752828) Filer | Form ARS | |
| 11/07/2025 12:21 PM | Celularity (1752828) Filer | Form DEFA14A | |
| 11/03/2025 4:07 PM | Celularity (1752828) Filer | Form D Notice of Exempt Offering of Securities | |
| 10/28/2025 8:29 AM | Celularity (1752828) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/29/2025 4:17 PM | Celularity (1752828) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/29/2025 4:21 PM | Celularity (1752828) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/27/2025 8:15 AM | Celularity (1752828) Subject Lincoln Alternative Strategies LLC (2043812) Filed by | Form SCHEDULE 13G | |